Paralisia Supranuclear Progressiva

Aspectos Epidemiológicos e Etiopatogênicos

Autores

  • Paulo Eduardo Mestrineffi Carrilho Mestre em Neurologia pela FMUSP/SP. Neurologista da Neuroclfnica — Cascavel/PR
  • Egberto Reis Barbosa Doutor em Neurologia pela FMUSP/SP — Coordenador do Grupo de Estudo de Distúrbios do Movimento da Clínica Neurológica do Hospital das Clínicas da FMUSP/SP

DOI:

https://doi.org/10.34024/rnc.1999.v7.8958

Palavras-chave:

Paralisia supranuclear progressiva, aspectos epidemiológicos e etiopatogénicos

Resumo

A paralisia supranuclear progressiva (PSP) 6 uma das mais frequentes tormas de parkinsonismo-plus. Foi descrita no inicio da década de 60 por pesquisadores da Universidade de Toronto (Canada) e tem prevaléncia cerca de 100 vezes menor que a da doença de Parkinson. A PSP pertence ao numeroso grupo de doenças degenerativas do sistema nervoso central, cuja etiologia ainda 6 desconhecida. Contudo, nas últimas décadas surgiram alguns novos e interessantes dados relacionados aos mecanismos etiopatogénicos presentes nessa intrigante moléstia. Neste artigo os autores revisam e analisam essas informações.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol, 10:333-358,1964.

Carrilho PEM. Paralisia supranuclear progressiva. Aspectos clínicos e de neuroimagem. Sao Paulo, 1999:54-66. Dissertação de Mestrado, Faculdade de Medicina da Universidade de São Paulo.

Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol din, 10:341-359, 1992.

Brusa A, Peloso PF. An Introduction to Progressive Supranuclear Palsy. Roma, Libbey, 1994, p 3-10.

De Bruin VMS, Lees AJ. Subcortical neurofibrillary degeneration presenting as SRO and other related syndromes: a review of 90 pathologically verified cases. Mov Disord, 9:381-389, 1994.

Litvan I, Agyd Y, Jankovic J, Goetz C, Brands] JP, Lai EC, Wenning G, D'olhaberriague L, Verny M, Ray Chaudhuril K, Mckee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology, 46:922-930, 1996.

Barbosa ER, Carrilho PEM, Haddad MS, Limongi JCP, Scaff M. Progressive supranuclear palsy in Brazil; a clinical and neuroimaging findings in 16 patients. Mov Disord, 12 (Suppl 1):78, 1997.

Golbe LI, Davis PH, Schoemberg BS, Duvoisin RC. Prevalence of and natural history of progressive supranuclear palsy. Neurology, 38:1031-1034, 1988.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CO, Golbe LI, Grafman J, Growdon MD, Hallet M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDSSPSP International Workshop. Neurology, 47:1-9, 1996.

Litvan I, Mangone CA, Mckee A, of a/. Natural history of progressive supranuclear palsy (Steel e-RichardsonOlszewski syndrome) and clinical prediction of survival: a clinciopathological study. J Neurol Neurosurg Psychiatry, 60:615-620, 1996.

Scott D. Progressive supranuclear palsy in a Navajo. Rocky Mtn Med, J 67:35-37, 1970.

Uittti R, Evidente VGH, Dickson DW, Graff-Radford N. A kindred with familial progressive supranuclear palsy. Neurology, 52(Suppl):A227, 1999.

Dubas F, Gray F, Escourrolle R. Maladie de SteeleRichardson-Olszewski sans ophtalmoplégie. Six cas anatomo-cliniques. Rev Neurol (Paris), 139:407-416, 1983.

Ohara S, Kondo K, Morita H, Maruyama K, Ikeda S, Yanagisawa N. Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous marriage. Neurology, 42:1009-1014, 1992.

Tetrud JW, Golbe LI, Forno LS, Farmer PM. Autopsy-proven progressive supranuclear palsy in two siblings. Neurology, 46:931-934, 1996.

Elipe JG, Pernaute RS, Sandiumenge A, Yebenes JG. Clinical symptoms in relatives of probands with progressive supranuclear palsy. Neurology, 46 (Suppl):A386-387, 1996.

Golbe LI, Rubin RP, Cody RP, Belsh MD, Duvoisin RC, Grosmann C. Lepore FE, Mark MH, Schdeo RC, Sage JI, Zimmerman Jr TR. Follow-up study of risk factors in progressive supranuclear palsy. Neurology, 47:148-154, 1996.

Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS. Risk factors for progressive supranuclear palsy. Neurology, 38:1546 -1552, 1988.

Golbe LI, Dickson OW. Familial autopsy-proven progressive supranuclear palsy Neurology, 45:A255, 1995.

Litvan I. Progressive supranuclear palsy revisited. Acta Neural Scand, 98:73-84, 1998.

Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wierderholt W, Hansen L, Maslian E, Thal LJ et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol, 41:277-281, 1997.

Tuite PJ, Malik RA, Knopman DS, Brent Clark H. Are CBGD and PSP related? Clinical CBGD in two siblings: one with CBGD pathology and other with PSP pathology. Neurology, 52 (Suppl 2):A225, 1999.

Villares J, Strada 0, Facheux B, Javoy-Agid F, Agid Y, Hirsch EC. Loss of striatal high afinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease. Neurosci (Lett), 182:59-62, 1994.

Di Monte DA, Laraty Y, Jankovic J, Sandy MS, Jewel SA, Langston JW. Muscle mitochondria! ATP production in progressive supranuclear palsy. J Neurochem, 62:1631- 1634, 1994.

Frederico F, Simone IL, Luciero V et at Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 62:239-42, 1997

Sian J, Dexter DT, Lees AJ et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol, 36:333-4, 1994.

McCrank E, Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can J Psychiatry, 34:934-936, 1989.

Masters FL, Harris JO, Gadjusek DC, Gibbs CJJr; Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurence and the significance of familial and sporadic clustering. Ann Neurol, 5:177-188, 1979.

Wada S, Goya T, Matsukado Y. Progressive supranuclear palsy after head injury. Case report. Clin Neurol (Tokyo), 29:496-502,

Downloads

Publicado

1999-04-30

Como Citar

Carrilho, P. E. M., & Barbosa, E. R. (1999). Paralisia Supranuclear Progressiva: Aspectos Epidemiológicos e Etiopatogênicos. Revista Neurociências, 7(2), 54–56. https://doi.org/10.34024/rnc.1999.v7.8958

Edição

Seção

Artigos Originais
Recebido: 2019-03-05
Publicado: 1999-04-30